Heparin and monitoring of peroral anticoagulant therapy
Bremmelgaard, A.
Ugeskrift for Laeger 148(21): 1275-1276
1986
ISSN/ISBN: 0041-5782 PMID: 3727111 Document Number: 279563
Document emailed within 1 workday
Related Documents
Eilertsen, H.; Asprang, A.F.; Ulveland, K.; Nerdrum, H.J. 1998: Peroral anticoagulant therapy--are the TT-values reliable? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(11): 1690-1692Matsuoka, T.; Inoue, K.; Mizuno, K.; Kita, Y.; Nakanishi, S.; Asai, S.; Taoka, R.; Soda, T.; Terai, A. 2012: Heparin as bridging anticoagulant and antiplatelet therapy during the perioperative period Hinyokika Kiyo. Acta Urologica Japonica 58(5): 223-226
Byshevskiĭ, A.S.; Sokolovskiĭ, S.R. 1982: Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin Voprosy Meditsinskoi Khimii 28(2): 30-34
Bernardi, P.; Cavazza, M.; Bastagli, L.; Fontana, F.; Ventura, C.; Spagnolo, N.; Guardigli, G. 1986: Anticoagulant therapy in myocardial infarct. Considerations based on data from the literature and personal results obtained by the administration of subcutaneous heparin-calcium La Clinica Terapeutica 119(2): 91-109
Bechtold, H.; Kleist, P.; Landgraf, K.; Möser, K. 1994: Effect of low-dosage intravenous nitrate therapy on the anticoagulant effect of heparin Medizinische Klinik 89(7): 360-366
Hoffmann, J.J. 1985: Monitoring the intrinsic pathway of coagulation during heparin therapy Thrombosis and Haemostasis 53(1): 161
Uszyński, L.; Klukowski, M. 1984: Monitoring heparin therapy by the determination of blood coagulation time using kaolin Polski Tygodnik Lekarski 39(46): 1505-1507
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Dalmora, S.L.; Assaf, G.S.; Dalmora, M.E.; Vaucher, L.C.; Vaccari, S.F. 1991: Determination of anticoagulant activity of heparin Revista do Hospital das Clinicas 46(2): 59-62
Bychko, S.M.; Kharlamova, V.N. 1975: The anticoagulant properties of different heparin fractions Biulleten' Eksperimental'noi Biologii i Meditsiny 79(2): 61-63
Krupiński, K.; Bielawiec, M.; Breddin, H.K. 1994: Antithrombotic properties of heparin independent of its anticoagulant activity Acta Haematologica Polonica 25(3): 243-251
Ofosu, F.A. 1988: Mechanisms for the anticoagulant effect of heparin and related polysaccharides Nouvelle Revue Francaise d'Hematologie 30(3): 155-160
Kudriashov, B.A.; Liapina, L.A.; Azieva, L.D. 1990: The content of a heparin-like anticoagulant in the flowers of the meadowsweet (Filipendula ulmaria) Farmakologiia i Toksikologiia 53(4): 39-41
Millot, F.; Bara, L.; Etienne, J.; Samama, M.; Laruelle, P. 1987: Lipolytic and anticoagulant activities of heparin and one of its low molecular weight derivatives Nouvelle Revue Francaise d'Hematologie 29(6): 397-400
Strukova, S.M.; Khlebnikova, T.G.; Umarova, B.A.; Kulibali, M. 1984: Heparin secretion by mast cells as an index of the status of the anticoagulant system Biulleten' Eksperimental'noi Biologii i Meditsiny 97(2): 131-134
Burg, M.; Ostendorf, T.; Mooney, A.; Koch, K.M.; Floege, J. 1997: Treatment of experimental mesangioproliferative glomerulonephritis with non-anticoagulant heparin: therapeutic efficacy and safety Laboratory Investigation; A Journal of Technical Methods and Pathology 76(4): 505-516
Shammas, N.W.; Lemke, J.H.; Dippel, E.J.; McKinney, D.E.; Takes, V.S.; Youngblut, M.; Harris, M.; Harb, C.; Kapalis, M.J.; Holden, J. 2003: In-hospital complications of peripheral vascular interventions using unfractionated heparin as the primary anticoagulant Journal of Invasive Cardiology 15(5): 242-246
Schneider, T.; Heuer, B.; Deller, A.; Boesken, W.H. 2000: Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II) Wiener Klinische Wochenschrift 112(12): 552-555
Völker, W.; Böhm, A.; Schmidt, A.; Svahn, C.M.; Gellerbring, A.K.; Mattsson, C.; Ekvärn, S.; Robenek, H.; Buddecke, E. 1995: Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin Arzneimittel-Forschung 45(5): 546-550
Zimmermann, R.E.; Schwering, H.; Wittrin, G.; Hollenders, T. 1981: Control of low-dose heparin therapy using photometry to detect biologically active heparin Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(5): 316-319